Holdings of Horizon Kinetics Medical ETF
Listed Funds Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 18.2M $ including 16.7M $ in equities, 92.1 %
- Positions
- 31 in 4 countries
- Top ten
- 65.3 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 3,077 | 2.8M $ | 15.59 % |
| 2 | AbbVie Inc | 7,034 | 1.5M $ | 8.43 % |
| 3 | Novartis AG | 8,791 | 1.3M $ | 7.40 % |
| 4 | Johnson & Johnson | 4,401 | 1.1M $ | 5.93 % |
| 5 | AstraZeneca PLC | 5,256 | 1M $ | 5.71 % |
| 6 | Bristol-Myers Squibb Co | 15,348 | 930.9K $ | 5.13 % |
| 7 | Ionis Pharmaceuticals Inc | 11,428 | 858.1K $ | 4.73 % |
| 8 | Amgen Inc | 2,161 | 760.3K $ | 4.19 % |
| 9 | Alnylam Pharmaceuticals Inc | 2,272 | 751.7K $ | 4.14 % |
| 10 | Alkermes PLC | 21,099 | 746.1K $ | 4.11 % |
| 11 | Merck & Co Inc | 6,154 | 740.3K $ | 4.08 % |
| 12 | Pfizer Inc | 23,736 | 666.5K $ | 3.67 % |
| 13 | GSK PLC | 10,319 | 569.5K $ | 3.14 % |
| 14 | Biogen Inc | 2,857 | 523.8K $ | 2.89 % |
| 15 | Regeneron Pharmaceuticals, Inc. | 660 | 509.9K $ | 2.81 % |
| 16 | CRISPR Therapeutics AG | 9,671 | 460K $ | 2.53 % |
| 17 | Beam Therapeutics Inc | 8,791 | 209.5K $ | 1.15 % |
| 18 | Intellia Therapeutics Inc | 13,188 | 169.1K $ | 0.93 % |
| 19 | Vanda Pharmaceuticals Inc | 23,736 | 164K $ | 0.90 % |
| 20 | Sandoz Group AG | 1,760 | 137.6K $ | 0.76 % |
| 21 | GALECTIN THERAPEUTICS INC | 49,226 | 137.3K $ | 0.76 % |
| 22 | Haleon PLC | 12,900 | 129.1K $ | 0.71 % |
| 23 | Replimune Group Inc | 13,188 | 100.9K $ | 0.56 % |
| 24 | Editas Medicine Inc | 29,010 | 71.7K $ | 0.39 % |
| 25 | GE HealthCare Technologies Inc | 880 | 62.6K $ | 0.35 % |
| 26 | Bicycle Therapeutics PLC | 13,188 | 61.2K $ | 0.34 % |
| 27 | Viatris Inc | 3,272 | 44.2K $ | 0.24 % |
| 28 | Allogene Therapeutics Inc | 17,582 | 42.9K $ | 0.24 % |
| 29 | Lantern Pharma Inc | 26,373 | 36.1K $ | 0.20 % |
| 30 | Pacific Biosciences of California Inc | 10,551 | 13.9K $ | 0.08 % |
| 31 | Decoy Therapeutics Inc | 21 | 135.5 $ | 0.00 % |
Sector breakdown
- Health care 85.2 %
- Consumer staples 0.8 %
- Unattributed 14.1 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 81.2 %
- United Kingdom 10.7 %
- Ireland 4.5 %
- Switzerland 3.6 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 24 | 13.6M $ | 81.21 % |
| 2 | United Kingdom | 4 | 1.8M $ | 10.75 % |
| 3 | Ireland | 1 | 746.1K $ | 4.46 % |
| 4 | Switzerland | 2 | 597.7K $ | 3.58 % |
Cite this page
Titelia. "Holdings of Horizon Kinetics Medical ETF". https://titelia.com/en/funds/S000078972